Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (376)	6/22/1998 9:54:00 AM
From: Perry	Read Replies (1) \| Respond to of 1722

Pfizer sees "awesome" Viagra sales in Malaysia KUALA LUMPUR, June 21 (Reuters) - U.S. drugs giant Pfizer Inc PFE.N expects "awesome sales" of its impotence drug Viagra in Malaysia, the local Sunday Mail newspaper reported. The company has been getting hundreds of calls daily enquiring about the drug, Radzmi Rahmat, managing director of Pfizer in Malaysia, Singapore and Brunei, was quoted saying. The drug is awaiting Health Ministry approval and is expected to be available in Malaysia in three months' time. "Even by conservative estimates, the probable sales figures are rather mind-boggling," Radzmi said. The drug costs $10 a pill in the United States, equivalent to 40 Malaysian ringgit. Radzmi, who is also president of the Pharmaceutical Association of Malaysia, estimated that Viagra would be sought by about half a million Malaysian men when it is introduced here. "Assuming each man consumes an average of four tablets a month, this totals to one man spending approximately 1,900 ringgit a year. Multiply this by the 500,000 men estimated to be wanting to take Viagra -- and it comes up close to one billion ringgit a year," he said. Radzmi said 65 Malaysians have tried the drug in a six-month clinical trial that ended in March. "Based on the doctors' comments, the patients were very satisfied. In fact, these are the men who want the government to approve the drug as soon as possible," he said. ($=3.9 ringgit) REUTERS Rtr 01:49 06-21-98 Copyright 1998, Reuters News Service

To: Anthony Wong who wrote (376)	6/22/1998 12:23:00 PM
From: Anthony Wong	Respond to of 1722

Pfizer Inc. Cut to 'Hold' at Furman Selz Bloomberg News June 22, 1998, 6:43 a.m. PT Princeton, New Jersey, June 22 (Bloomberg Data) -- Pfizer Inc. (PFE US) was downgraded to ''hold'' from ''buy'' by analyst James E. Flynn at Furman Selz Inc. -- Andrew Bekoff in Princeton, New Jersey, (609)279-3652